{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:29:39Z","timestamp":1790008179294,"version":"4.0.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Gene Ontology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In China, there is a long history and rich clinical experience in treating nonalcoholic steatohepatitis (NASH) with traditional Chinese herbal medicines, including Chai Hu Shu Gan San. This study aims to investigate the potential regulatory effects of Chaihu Shugan San (CSS) on liver lipid metabolism and inflammatory damage in mice with experimental nonalcoholic steatohepatitis (NASH) induced by a choline-deficient high-fat diet (CDHFD). Utilizing network pharmacology, we systematically explore the mechanisms of action and therapeutic potential of CSS against NASH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Potential targets in CSS and targets for NASH were identified using online databases. Functional enrichment and protein\u2013protein interaction analyses were conducted to identify hub-targeted genes and elucidate the underlying molecular mechanisms. The affinities of active compounds in CSS with hub-targeted genes were evaluated using molecular docking. Finally, hub-targeted genes were validated through real-time polymerase chain reaction, western blotting, and immunofluorescence in choline-deficient high-fat diet mice, both with and without CSS treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>CSS reduces serum ALT and AST levels in NASH mice(P &amp;lt; 0.05) and ameliorates ballooning degeneration in the livers of NASH mice, thereby lowering the NAS score(P &amp;lt; 0.05). Including naringenin, high-performance liquid chromatography\/mass spectrometrys identified 12 chromatographic peaks. Based on network pharmacology analysis, CSS contains a total of 103 active compounds and 877 target genes. Transferase activity represents a potential mechanism for therapeutic intervention of CSS in NASH. The transcriptional levels and protein expression of the SIRT1 gene in NASH mice are significantly increased by CSS (P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Naringenin is probable active compound in CSS and SIRT1 is the hub gene by which CSS is involved in NASH treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgae103","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:10:03Z","timestamp":1725912603000},"page":"1521-1533","source":"Crossref","is-referenced-by-count":4,"title":["Deciphering the mechanism of Chaihu Shugan San in the treatment of nonalcoholic steatohepatitis using network pharmacology and molecular docking"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-5531","authenticated-orcid":false,"given":"Yi","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihui","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-7666","authenticated-orcid":false,"given":"Jingjie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University , Beijing 100050 ,","place":["China"]},{"name":"Clinical Center for Metabolic Associated Fatty Liver Disease, Capital Medical University , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"2024110408190458400_CIT0001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024110408190458400_CIT0002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13543784.2022.2032640","article-title":"Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials","volume":"31","author":"Aggarwal","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"key":"2024110408190458400_CIT0003","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J Hepatol"},{"key":"2024110408190458400_CIT0004","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"key":"2024110408190458400_CIT0005","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"2024110408190458400_CIT0006","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application","volume":"11","author":"Xu","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024110408190458400_CIT0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13020-024-00894-1","article-title":"Integrated traditional Chinese and western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies","volume":"19","author":"Ding","year":"2024","journal-title":"Chin Med"},{"key":"2024110408190458400_CIT0008","doi-asserted-by":"crossref","first-page":"1381712","DOI":"10.3389\/fphar.2024.1381712","article-title":"Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Pharmacol"},{"key":"2024110408190458400_CIT0009","first-page":"129","article-title":"The clinical efficacy of Chaihu Shugan San on patients with liver depression and spleen deficiency type non-alcoholic fatty liver disease and its impact on the gut microbiota(in Chinese)","volume":"27","author":"Xie","year":"2021","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"2024110408190458400_CIT0010","doi-asserted-by":"crossref","first-page":"e37052","DOI":"10.1097\/MD.0000000000037052","article-title":"Efficacy of traditional Chinese medicine combined with silibinin on nonalcoholic fatty liver disease: a meta-analysis and systematic review","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"2024110408190458400_CIT0011","doi-asserted-by":"crossref","first-page":"1086078","DOI":"10.3389\/fimmu.2023.1086078","article-title":"Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"2024110408190458400_CIT0012","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1111\/jcmm.15166","article-title":"A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors","volume":"24","author":"Nie","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2024110408190458400_CIT0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11655-016-2252-4","article-title":"Protective effects of Chaihu Shugan San () on nonalcoholic fatty liver disease in rats with insulin resistance","volume":"24","author":"Jiang","year":"2018","journal-title":"Chin J Integr Med"},{"key":"2024110408190458400_CIT0014","doi-asserted-by":"crossref","first-page":"9390786","DOI":"10.1155\/2018\/9390786","article-title":"Chaihu","volume":"2018","author":"Liang","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"2024110408190458400_CIT0015","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1039\/C5NP00005J","article-title":"Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products","volume":"32","author":"Kibble","year":"2015","journal-title":"Nat Prod Rep"},{"key":"2024110408190458400_CIT0016","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/ptr.7411","article-title":"Network pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment","volume":"36","author":"Cheung","year":"2022","journal-title":"Phytother Res"},{"key":"2024110408190458400_CIT0017","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fphar.2020.01035","article-title":"Uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network pharmacology model","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024110408190458400_CIT0018","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41598-022-04769-z","article-title":"Reveals of quercetin\u2019s therapeutic effects on oral lichen planus based on network pharmacology approach and experimental validation","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"key":"2024110408190458400_CIT0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminform"},{"key":"2024110408190458400_CIT0020","doi-asserted-by":"crossref","first-page":"8706589","DOI":"10.1155\/2019\/8706589","article-title":"A network pharmacology approach to reveal the underlying mechanisms of Paeonia lactiflora pall. on the treatment of Alzheimer\u2019s Disease","volume":"2019","author":"Zeng","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"2024110408190458400_CIT0021","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"Xu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"2024110408190458400_CIT0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","article-title":"Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease","volume":"145","author":"Tao","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"2024110408190458400_CIT0023","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2024110408190458400_CIT0024","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"2024110408190458400_CIT0025","doi-asserted-by":"crossref","first-page":"9965906","DOI":"10.1155\/2021\/9965906","article-title":"Exploring the molecular mechanism of action of Yinchen Wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation","volume":"2021","author":"Ye","year":"2021","journal-title":"Biomed Res Int"},{"key":"2024110408190458400_CIT0026","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J Biol Chem"},{"key":"2024110408190458400_CIT0027","doi-asserted-by":"crossref","first-page":"101646","DOI":"10.1016\/j.compmedimag.2019.101646","article-title":"Unsupervised method for normalization of hematoxylin-eosin stain in histological images","volume":"77","author":"Tosta","year":"2019","journal-title":"Comput Med Imaging Graph"},{"key":"2024110408190458400_CIT0028","doi-asserted-by":"crossref","first-page":"106153","DOI":"10.1016\/j.cmpb.2021.106153","article-title":"Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides","volume":"207","author":"Qu","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"2024110408190458400_CIT0029","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"2024110408190458400_CIT0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"2024110408190458400_CIT0031","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12986-023-00749-w","article-title":"A high-trans fat, high-carbohydrate, high-cholesterol, high-cholate diet-induced nonalcoholic steatohepatitis mouse model and its hepatic immune response","volume":"20","author":"Zhang","year":"2023","journal-title":"Nutr Metab"},{"key":"2024110408190458400_CIT0032","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3390\/ijms20092325","article-title":"Arazyme suppresses hepatic steatosis and steatohepatitis in diet-induced non-alcoholic fatty liver disease-like mouse model","volume":"20","author":"Li","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024110408190458400_CIT0033","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1211\/jpp.61.10.0016","article-title":"Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity","volume":"61","author":"Jayaraman","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"2024110408190458400_CIT0034","doi-asserted-by":"crossref","first-page":"90892","DOI":"10.1007\/s11356-023-28454-4","article-title":"Naringin and naringenin counteract taxol-induced liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation","volume":"30","author":"Khaled","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"2024110408190458400_CIT0035","doi-asserted-by":"crossref","first-page":"115113","DOI":"10.1016\/j.biopha.2023.115113","article-title":"Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway","volume":"165","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2024110408190458400_CIT0036","doi-asserted-by":"crossref","first-page":"16210","DOI":"10.1038\/s41598-019-52736-y","article-title":"Isorhamnetin alleviates steatosis and fibrosis in mice with nonalcoholic steatohepatitis","volume":"9","author":"Ganbold","year":"2019","journal-title":"Sci Rep"},{"key":"2024110408190458400_CIT0037","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.orcp.2015.08.004","article-title":"Synergistic interactions of apigenin, naringin, quercetin and emodin on inhibition of 3T3-L1 preadipocyte differentiation and pancreas lipase activity","volume":"10","author":"Guo","year":"2016","journal-title":"Obes Res Clin Pract"},{"key":"2024110408190458400_CIT0038","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/nu14163437","article-title":"Synergism potentiates oxidative antiproliferative effects of naringenin and quercetin in MCF-7 breast cancer cells","volume":"14","author":"Rhman","year":"2022","journal-title":"Nutrients"},{"key":"2024110408190458400_CIT0039","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/molecules29112630","article-title":"Kaempferol alleviates hepatic injury in nonalcoholic steatohepatitis (NASH) by suppressing neutrophil-mediated NLRP3-ASC\/TMS1-caspase 3 signaling","volume":"29","author":"Yang","year":"2024","journal-title":"Molecules"},{"key":"2024110408190458400_CIT0040","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1002\/fsn3.3700","article-title":"Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice","volume":"11","author":"Cao","year":"2023","journal-title":"Food Sci Nutr"},{"key":"2024110408190458400_CIT0041","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"key":"2024110408190458400_CIT0042","doi-asserted-by":"crossref","first-page":"e0164191","DOI":"10.1371\/journal.pone.0164191","article-title":"Evaluation of methionine content in a high-fat and choline-deficient diet on body weight gain and the development of non-alcoholic steatohepatitis in mice","volume":"11","author":"Chiba","year":"2016","journal-title":"PLoS One"},{"key":"2024110408190458400_CIT0043","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1089\/acm.2015.0200","article-title":"Transcriptomic profiling of adipose tissue in obese women in response to acupuncture catgut embedding therapy with moxibustion","volume":"22","author":"Garcia-Vivas","year":"2016","journal-title":"J Altern Complement Med"},{"key":"2024110408190458400_CIT0044","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2024110408190458400_CIT0045","doi-asserted-by":"crossref","first-page":"e0033","DOI":"10.1097\/HC9.0000000000000033","article-title":"The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance","volume":"7","author":"Gill","year":"2023","journal-title":"Hepatol Commun"},{"key":"2024110408190458400_CIT0046","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/bbrc.1999.0897","article-title":"Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity","volume":"260","author":"Frye","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2024110408190458400_CIT0047","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fnins.2018.00778","article-title":"Sirtuins in neuroendocrine regulation and neurological diseases","volume":"12","author":"Fujita","year":"2018","journal-title":"Front Neurosci"},{"key":"2024110408190458400_CIT0048","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2017.01.028","article-title":"Berberine protects against ischemia\/reperfusion injury after orthotopic liver transplantation via activating Sirt1\/FoxO3\u03b1 induced autophagy","volume":"483","author":"Lin","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2024110408190458400_CIT0049","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12020-014-0465-x","article-title":"Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients","volume":"49","author":"Mariani","year":"2015","journal-title":"Endocrine"},{"key":"2024110408190458400_CIT0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"Hs","year":"2010","journal-title":"Cell Metab"},{"key":"2024110408190458400_CIT0051","doi-asserted-by":"crossref","first-page":"1230783","DOI":"10.3389\/fphar.2023.1230783","article-title":"Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses","volume":"14","author":"He","year":"2023","journal-title":"Front Pharmacol"},{"key":"2024110408190458400_CIT0052","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13063-017-1979-3","article-title":"The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial","volume":"18","author":"M","year":"2017","journal-title":"Trials"},{"key":"2024110408190458400_CIT0053","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7150\/ijbs.6.682","article-title":"Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition","volume":"6","author":"Wang","year":"2010","journal-title":"Int J Biol Sci"},{"key":"2024110408190458400_CIT0054","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J Biol Chem"},{"key":"2024110408190458400_CIT0055","doi-asserted-by":"crossref","first-page":"13183","DOI":"10.1021\/acs.jafc.8b05756","article-title":"Inhibition of P2X7R-NLRP3 inflammasome activation by Pleurotus citrinopileatus: a possible protective role in alcoholic hepatosteatosis","volume":"66","author":"Li","year":"2018","journal-title":"J Agric Food Chem"},{"key":"2024110408190458400_CIT0056","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/acs.jafc.9b04259","article-title":"Pterostilbene improves hepatic lipid accumulation via the MiR-34a\/sirt1\/SREBP-1 pathway in fructose-fed rats","volume":"68","author":"Wu","year":"2020","journal-title":"J Agric Food Chem"},{"key":"2024110408190458400_CIT0057","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1101\/gad.1901210","article-title":"Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid\/cholesterol regulator SREBP","volume":"24","author":"Walker","year":"2010","journal-title":"Genes Dev"},{"key":"2024110408190458400_CIT0058","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10565-019-09463-x","article-title":"Activation of SIRT1 by","volume":"35","author":"Sim","year":"2019","journal-title":"Cell Biol Toxicol"},{"key":"2024110408190458400_CIT0059","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"2024110408190458400_CIT0060","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/nu11112702","article-title":"Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation","volume":"11","author":"Lee","year":"2019","journal-title":"Nutrients"},{"key":"2024110408190458400_CIT0061","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J"},{"key":"2024110408190458400_CIT0062","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1210\/en.2009-1013","article-title":"Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+\/","volume":"151","author":"Xu","year":"2010","journal-title":"Endocrinology"},{"key":"2024110408190458400_CIT0063","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab"},{"key":"2024110408190458400_CIT0064","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1073\/pnas.0802917105","article-title":"Sirt1 protects against high-fat diet-induced metabolic damage","volume":"105","author":"Pfluger","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024110408190458400_CIT0065","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.2147\/DMSO.S437865","article-title":"Biological role and related natural products of SIRT1 in nonalcoholic fatty liver","volume":"16","author":"Meng","year":"2023","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"2024110408190458400_CIT0066","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.26491","article-title":"Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-\u03b1-converting enzyme activity in mice","volume":"58","author":"Jiang","year":"2013","journal-title":"Hepatology (Baltimore, MD)"},{"key":"2024110408190458400_CIT0067","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2021.09.008","article-title":"Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function","volume":"76","author":"da Silva Lima","year":"2022","journal-title":"J Hepatol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/11\/1521\/60213089\/rgae103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/11\/1521\/60213089\/rgae103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T08:19:52Z","timestamp":1730708392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/76\/11\/1521\/7754056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":67,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,9,9]]},"published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgae103","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,9]]}}}